{{Rsnum
|rsid=6501455
|Chromosome=17
|position=71205670
|Orientation=plus
|GMAF=0.3825
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 17.7 | 56.6 | 25.7
| HCB | 48.9 | 37.2 | 13.9
| JPT | 28.3 | 54.0 | 17.7
| YRI | 58.5 | 35.4 | 6.1
| ASW | 50.9 | 40.4 | 8.8
| CHB | 48.9 | 37.2 | 13.9
| CHD | 38.9 | 49.1 | 12.0
| GIH | 46.5 | 37.6 | 15.8
| LWK | 59.6 | 33.0 | 7.3
| MEX | 46.6 | 39.7 | 13.8
| MKK | 47.1 | 41.3 | 11.6
| TSI | 42.2 | 41.2 | 16.7
| HapMapRevision=28
}}{{Report GE
|PubMed=17603485
|Source=journal
|AffyProbeset=SNP_A-8681224
|AffyOrientation=reverse
|AlleleA=C
|AlleleB=T
|onGW5=0
|rsid=6501455
|ancestral=A
|RiskPopulation=EU
|RiskAllele=A
|CaseFreq=
|ControlFreq=0.53
|OddsRatioHet=
|OddsRatioHom=
|OddsRatioAll=1.14
|Disease=Prostate cancer
|DiseaseSymbol=PC
}}

rs6501455 increases susceptibility to Prostate cancer 1.14 times for carriers of the A allele {{PMID|17603485}}

{{PMID Auto
|PMID=21086507
|Title=GWAS SNP Replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP)
}}

{{PMID|20690139}} Meta-analysis of genome-wide and replication association studies on prostate cancer.

{{PMID|21456070|OA=1
}} GWAS SNP Replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP).

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}